User:Hugues Abriel: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Hugues Abriel
No edit summary
No edit summary
 
(4 intermediate revisions by 2 users not shown)
Line 1: Line 1:
Hugues Abriel has been trained both as a life-science scientist and medical doctor (MD PhD), in Switzerland. After two years spent doing clinical work with patients, he is involved since ten years in research projects aiming at elucidating the roles of ion channels in human diseases (channelopathies), with a special emphasis on cardiac arrhythmias. He is now an assistant Professor (Swiss National Science Foundation Professor) at the University of Lausanne, Switzerland, Department of pharmacology and toxicology and service of cardiology, where he leads a research group.  
{{AccountNotLive}}
Hugues Abriel has been trained both as a life-science scientist and medical doctor (MD PhD), in Switzerland. After two years spent doing clinical work with patients, he is involved since ten years in research projects aiming at elucidating the roles of ion channels in human diseases (channelopathies), with a special emphasis on cardiac arrhythmias. He is now an assistant Professor (Swiss National Science Foundation Professor) at the University of Lausanne, Switzerland, Department of pharmacology and toxicology and service of cardiology, where he leads a research group.


[[Category:CZ Authors|Abriel, Hugues]]
[[Category:CZ Authors|Abriel, Hugues]]
[[Category:Inactive CZ Editors|Abriel, Hugues]]
[[Category:Inactive Biology Editors|Abriel, Hugues]]
[[Category:Inactive Health Sciences Editors|Abriel, Hugues]]

Latest revision as of 02:58, 22 November 2023


The account of this former contributor was not re-activated after the server upgrade of March 2022.


Hugues Abriel has been trained both as a life-science scientist and medical doctor (MD PhD), in Switzerland. After two years spent doing clinical work with patients, he is involved since ten years in research projects aiming at elucidating the roles of ion channels in human diseases (channelopathies), with a special emphasis on cardiac arrhythmias. He is now an assistant Professor (Swiss National Science Foundation Professor) at the University of Lausanne, Switzerland, Department of pharmacology and toxicology and service of cardiology, where he leads a research group.